Yale New Haven Health System on Tuesday offered voluntary retirement packages to certain senior employees, stating the effort is necessary to navigate “a rapidly changing healthcare landscape.”
Rallybio Corp., a New Haven-based biotechnology company developing therapies for rare diseases, said Tuesday it has agreed to sell one of those therapies to Utah-based Recursion Pharmaceuticals for up to $25 million.